Your browser doesn't support javascript.
loading
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte, Lisette M; Cnossen, Marjon H; van Hest, Reinier M; Driessens, Mariette H E; Fijnvandraat, Karin; Polinder, Suzanne; Beckers, Erik A M; Coppens, Michiel; Eikenboom, Jeroen; Laros-van Gorkom, Britta A P; Meijer, Karina; Nieuwenhuizen, Laurens; Mauser-Bunschoten, Evelien P; Leebeek, Frank W G; Mathôt, Ron A A; Kruip, Marieke J H A.
Afiliação
  • Schütte LM; Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Cnossen MH; Department of Paediatric Haematology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van Hest RM; Department of Hospital Pharmacy-Clinical Pharmacology Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Driessens MHE; Netherlands Haemophilia Patient Society, (NVHP), Nijkerk, The Netherlands.
  • Fijnvandraat K; Department of Paediatric Haematology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, The Netherlands.
  • Polinder S; Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands.
  • Beckers EAM; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Coppens M; Department of Haematology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Eikenboom J; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Laros-van Gorkom BAP; Department of Thrombosis and Haemostasis, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
  • Meijer K; Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Nieuwenhuizen L; Department of Haematology, Universitair Medisch Centrum Groningen, Groningen, The Netherlands.
  • Mauser-Bunschoten EP; Department of Haematology, Maxima Medical Centre, Eindhoven, Eindhoven, Noord-Brabant, The Netherlands.
  • Leebeek FWG; Van Creveldclinic, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Mathôt RAA; Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Kruip MJHA; Department of Hospital Pharmacy-Clinical Pharmacology Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
BMJ Open ; 9(4): e022719, 2019 04 23.
Article em En | MEDLINE | ID: mdl-31015264

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Desamino Arginina Vasopressina / Hemofilia A / Hemostasia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Desamino Arginina Vasopressina / Hemofilia A / Hemostasia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda